Canada-based marijuana grower Tilray Inc. (NASDAQ: TLRY) added nearly 30% to its share price on Tuesday to close at $154.98, after posting a new post-IPO high of $155.10. In Wednesday’s premarket trading, Tilray soared another 40% to trade at more than $215 a share.
The company had sales of $9.7 million in the June quarter and a market cap of nearly $14.5 billion following Tuesday’s share price jump. Tilray’s quarterly loss came to nearly $11 million ($0.17 per share on a GAAP basis).
Tuesday’s big move was the result of the announced approval by the U.S. Drug Enforcement Agency (DEA) for Tilray to export cannabis to the United States for medical research purposes. A week earlier the company received approval to export medical cannabis flower to Germany. Tilray already had gained approval to export cannabis-derived oils to Germany.
Marijuana for legal recreational and adult use goes on sale next month in Canada, and that could drive Tilray sales higher. The company has struck deals with some Canadian firms to supply marijuana for use in recreational and adult-use products. But that hardly seems to justify the nosebleed share price levels.
But if you don’t believe that Tilray stock can continue to soar at this astronomical pace, it’ll cost you a stock-borrow fee of as much as 600% to place your short bet against the stock. According to a report at MarketWatch, short sellers have lost nearly $500 million so far betting against Tilray and a basket of other cannabis stocks.
The party in marijuana stocks began a month ago with the announcement that beverage giant Constellation Brands had invested $4.2 billion in Canopy Growth, another Canadian grow company. Other big beverage makers like Molson Coors and, more recently, Coca-Cola were reportedly looking for partners as they weighed creating marijuana-infused drinks.
Predicting the outcome of all this is not hard, but predicting the timing is virtually impossible. Is the run for Tilray and other cannabis-related firms a temporary flash (like, for example, bitcoin) or is this really the start of something that will endure? If the former, is there still time to join the party? And if the latter, is now the time to place a short bet?
Tilray shares traded up more than 19% at last look with a price of $185.10. The stock’s new post-IPO range is $20.10 to $236.00.
24/7 Wall St.Take Charge of Your Retirement In Just A Few Minutes (Sponsor)
Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor.
Here’s how it works:
- Answer a Few Simple Questions. Tell us a bit about your goals and preferences—it only takes a few minutes!
- Get Matched with Vetted Advisors Our smart tool matches you with up to three pre-screened, vetted advisors who serve your area and are held to a fiduciary standard to act in your best interests. Click here to begin
- Choose Your Fit Review their profiles, schedule an introductory call (or meet in person), and select the advisor who feel is right for you.
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.